Lin Y - Search Results

1

Red Blood Cell Transfusion: 2023 AABB International Guidelines.

Carson JL, Stanworth SJ, Guyatt G, Valentine S, Dennis J, Bakhtary S, Cohn CS, Dubon A, Grossman BJ, Gupta GK, Hess AS, Jacobson JL, Kaplan LJ, Lin Y, Metcalf RA, Murphy CH, Pavenski K, Prochaska MT, Raval JS, Salazar E, Saifee NH, Tobian AAR, So-Osman C, Waters J, Wood EM, Zantek ND, Pagano MB. Carson JL, et al. Among authors: lin y. JAMA. 2023 Nov 21;330(19):1892-1902. doi: 10.1001/jama.2023.12914. JAMA. 2023. PMID: 37824153

2

Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies.

Webert KE, Cserti CM, Hannon J, Lin Y, Pavenski K, Pendergrast JM, Blajchman MA. Webert KE, et al. Among authors: lin y. Transfus Med Rev. 2008 Jan;22(1):1-34. doi: 10.1016/j.tmrv.2007.09.001. Transfus Med Rev. 2008. PMID: 18063190 Free PMC article. Review.

3

Blood group antigens and normal red blood cell physiology: a Canadian blood services research and development symposium.

Lin Y, Pavenski K, Saidenberg E, Branch DR. Lin Y, et al. Transfus Med Rev. 2009 Oct;23(4):292-309. doi: 10.1016/j.tmrv.2009.06.004. Transfus Med Rev. 2009. PMID: 19765518 No abstract available.

4

A systematic assessment of the quality of reporting for platelet transfusion studies.

Delaney M, Meyer E, Cserti-Gazdewich C, Haspel RL, Lin Y, Morris A, Pavenski K, Dzik WH, Murphy M, Slichter S, Wang G, Dumont LJ, Heddle N. Delaney M, et al. Among authors: lin y. Transfusion. 2010 Oct;50(10):2135-44. doi: 10.1111/j.1537-2995.2010.02691.x. Epub 2010 Oct 4. Transfusion. 2010. PMID: 20497518

5

Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis.

Lin Y, Stanworth S, Birchall J, Doree C, Hyde C. Lin Y, et al. CMAJ. 2011 Jan 11;183(1):E9-19. doi: 10.1503/cmaj.100408. Epub 2010 Nov 15. CMAJ. 2011. PMID: 21078742 Free PMC article. Review.

6

Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.

Lin Y, Stanworth S, Birchall J, Doree C, Hyde C. Lin Y, et al. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD005011. doi: 10.1002/14651858.CD005011.pub3. Cochrane Database Syst Rev. 2011. PMID: 21328270 Updated. Review.

7

Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.

Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C. Simpson E, et al. Among authors: lin y. Cochrane Database Syst Rev. 2012 Mar 14;(3):CD005011. doi: 10.1002/14651858.CD005011.pub4. Cochrane Database Syst Rev. 2012. PMID: 22419303 Review.

8

The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework.

Lin Y, Moltzan CJ, Anderson DR; National Advisory Committee on Blood and Blood Products. Lin Y, et al. Transfus Med. 2012 Dec;22(6):383-94. doi: 10.1111/j.1365-3148.2012.01164.x. Epub 2012 May 27. Transfus Med. 2012. PMID: 22630348 Free PMC article. Review.

9

Bleeding complications from the direct oral anticoagulants.

Sholzberg M, Pavenski K, Shehata N, Cserti-Gazdewich C, Lin Y. Sholzberg M, et al. Among authors: lin y. BMC Hematol. 2015 Dec 24;15:18. doi: 10.1186/s12878-015-0039-z. eCollection 2015. BMC Hematol. 2015. PMID: 26705474 Free PMC article.

10

Evaluating appropriate red blood cell transfusions: a quality audit at 10 Ontario hospitals to determine the optimal measure for assessing appropriateness.

Spradbrow J, Cohen R, Lin Y, Armali C, Collins A, Cserti-Gazdewich C, Lieberman L, Pavenski K, Pendergrast J, Webert K, Callum J. Spradbrow J, et al. Among authors: lin y. Transfusion. 2016 Oct;56(10):2466-2476. doi: 10.1111/trf.13737. Epub 2016 Jul 27. Transfusion. 2016. PMID: 27465485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49,097 results

Search Page